Dr. Kristy K. Ward

Gynecologic Oncology | Obstetrics and Gynecology | Oncology
1 Medical Ctr Dr, 
Morgantown, WV 
Accepting New Patients
Offers Telehealth
1 Medical Ctr Dr, 
Morgantown, WV 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kristy Ward is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Morgantown, West Virginia. Dr. Ward is rated as an Experienced provider by MediFind in the treatment of Newborn Low Blood Sugar. Her top areas of expertise are Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Bladder Reconstruction, and Hysterectomy. Dr. Ward is currently accepting new patients.

Her clinical research consists of co-authoring 34 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gynecologic Oncology
Obstetrics and Gynecology
Oncology
Licenses
Obstetrics & Gynecology in TX
Hospital Affiliations
West Virginia University Hospitals, Inc
Camden Clark Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

WEST VIRGINIA UNIVERSITY MEDICAL CORPORATION
1 Medical Ctr Dr, Morgantown, WV 26506

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
Enrollment Status: Completed
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drugs: Mirvetuximab Soravtansine, Paclitaxel, Topotecan, Pegylated liposomal doxorubicin
Study Phase: Phase 3
SORAYA: A Phase 3, Single Arm Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
SORAYA: A Phase 3, Single Arm Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
Enrollment Status: Completed
Publish Date: August 07, 2024
Intervention Type: Drug
Study Drug: Mirvetuximab Soravtansine
Study Phase: Phase 3
ENGOT-ov50 / GOG-3029 / INNOVATE-3: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer
ENGOT-ov50 / GOG-3029 / INNOVATE-3: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer
Enrollment Status: Completed
Publish Date: March 29, 2024
Intervention Type: Device, Drug
Study Drug: Paclitaxel
Study Phase: Phase 3
View 2 Less Clinical Trials

34 Total Publications

The elevated risk of ovarian clear cell carcinoma among Asian Pacific Islander women in the United States is not affected by birthplace.
The elevated risk of ovarian clear cell carcinoma among Asian Pacific Islander women in the United States is not affected by birthplace.
Journal: Gynecologic oncology
Published: August 19, 2019
Similar Doctors
Distinguished in Newborn Low Blood Sugar
Dr. Brian Casey
Neonatology | Medical Genetics | Obstetrics and Gynecology
Distinguished in Newborn Low Blood Sugar
Dr. Brian Casey
Neonatology | Medical Genetics | Obstetrics and Gynecology

West Virginia University Hospitals

1 Medical Center Dr, 
Morgantown, WV 
 (0.1 miles away)
304-243-3000
Languages Spoken:
English
See accepted insurances

Brian Casey is a Neonatologist and a Medical Genetics provider in Morgantown, West Virginia. Dr. Casey is rated as a Distinguished provider by MediFind in the treatment of Newborn Low Blood Sugar. His top areas of expertise are Gestational Diabetes, Preeclampsia, High Blood Pressure in Infants, Salpingo-Oophorectomy, and Tubal Ligation.

Experienced in Newborn Low Blood Sugar
Dr. Carrie D. Bennett
Obstetrics and Gynecology
Experienced in Newborn Low Blood Sugar
Dr. Carrie D. Bennett
Obstetrics and Gynecology

University Of Pittsburgh Physicians

300 Halket St, 
Pittsburgh, PA 
 (54.2 miles away)
Languages Spoken:
English
See accepted insurances

Carrie Bennett is an Obstetrics and Gynecologist in Pittsburgh, Pennsylvania. Dr. Bennett is rated as an Experienced provider by MediFind in the treatment of Newborn Low Blood Sugar. Her top areas of expertise are Newborn Low Blood Sugar and Ureteroscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ward's expertise for a condition
ConditionClose
        View All 20 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile